{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T21:14:44Z","timestamp":1791407684615,"version":"4.3.3"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,3]],"date-time":"2021-03-03T00:00:00Z","timestamp":1614729600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007217","name":"Health Services Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007217","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01DK104927"],"award-info":[{"award-number":["R01DK104927"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32AG57468"],"award-info":[{"award-number":["T32AG57468"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UL1TR002003"],"award-info":[{"award-number":["UL1TR002003"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["1I01BX003382"],"award-info":[{"award-number":["1I01BX003382"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006379","name":"Office of Research and Development","doi-asserted-by":"publisher","award":["20PRE35150022"],"award-info":[{"award-number":["20PRE35150022"]}],"id":[{"id":"10.13039\/100006379","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.ebiom.2021.103287","type":"journal-article","created":{"date-parts":[[2021,3,20]],"date-time":"2021-03-20T20:42:28Z","timestamp":1616272948000},"page":"103287","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Metabolomic analysis of a selective ABCA1 inducer in obesogenic challenge provides a rationale for therapeutic development"],"prefix":"10.1016","volume":"66","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4929-7389","authenticated-orcid":false,"given":"Cutler T.","family":"Lewandowski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4398-8798","authenticated-orcid":false,"given":"Md.Wasim","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5244-651X","authenticated-orcid":false,"given":"Manel","family":"BenAissa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oleksii","family":"Dubrovskyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha","family":"Ackerman-Berrier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary Jo","family":"LaDu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian T.","family":"Layden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7757-1739","authenticated-orcid":false,"given":"Gregory R.J.","family":"Thatcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ebiom.2021.103287_bib0001","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1208\/s12248-012-9429-3","article-title":"The liver X receptor agonist T0901317 protects mice from high fat diet-induced obesity and insulin resistance","volume":"15","author":"Gao","year":"2013","journal-title":"AAPS J"},{"issue":"11","key":"10.1016\/j.ebiom.2021.103287_bib0002","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1194\/jlr.M300135-JLR200","article-title":"The LXR ligand T0901317 induces severe lipogenesis in the db\/db diabetic mouse","volume":"44","author":"Chisholm","year":"2003","journal-title":"J Lipid Res"},{"key":"10.1016\/j.ebiom.2021.103287_bib0003","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/s12933-014-0149-0","article-title":"Liver X receptor agonist treatment attenuates cardiac dysfunction in type 2 diabetic db\/db mice","volume":"13","author":"He","year":"2014","journal-title":"Cardiovasc Diabetol"},{"issue":"12","key":"10.1016\/j.ebiom.2021.103287_bib0004","doi-asserted-by":"crossref","first-page":"3002","DOI":"10.1210\/me.2007-0156","article-title":"Dissection of the insulin-sensitizing effect of liver X receptor ligands","volume":"21","author":"Commerford","year":"2007","journal-title":"Mol Endocrinol"},{"issue":"5","key":"10.1016\/j.ebiom.2021.103287_bib0005","doi-asserted-by":"crossref","first-page":"E494","DOI":"10.1152\/ajpendo.00410.2013","article-title":"Skeletal muscle as a target of LXR agonist after long-term treatment: focus on lipid homeostasis","volume":"306","author":"Archer","year":"2014","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.ebiom.2021.103287_bib0006","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.cmet.2013.04.021","article-title":"Reciprocal regulation of hepatic and adipose lipogenesis by liver X receptors in obesity and insulin resistance","volume":"18","author":"Beaven","year":"2013","journal-title":"Cell Metab"},{"issue":"9","key":"10.1016\/j.ebiom.2021.103287_bib0007","doi-asserted-by":"crossref","first-page":"5419","DOI":"10.1073\/pnas.0830671100","article-title":"Activation of liver X receptor improves glucose tolerance through coordinate regulation of glucose metabolism in liver and adipose tissue","volume":"100","author":"Laffitte","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"issue":"10","key":"10.1016\/j.ebiom.2021.103287_bib0008","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1194\/jlr.M400257-JLR200","article-title":"Gene-selective modulation by a synthetic oxysterol ligand of the liver X receptor","volume":"45","author":"Quinet","year":"2004","journal-title":"J Lipid Res"},{"issue":"12","key":"10.1016\/j.ebiom.2021.103287_bib0009","doi-asserted-by":"crossref","first-page":"3486","DOI":"10.2337\/diabetes.51.12.3486","article-title":"Mechanisms of the triglyceride- and cholesterol-lowering effect of fenofibrate in hyperlipidemic type 2 diabetic patients","volume":"51","author":"Forcheron","year":"2002","journal-title":"Diabetes"},{"issue":"10","key":"10.1016\/j.ebiom.2021.103287_bib0010","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1016\/j.celrep.2017.05.032","article-title":"Hepatocyte ABCA1 deletion impairs liver insulin signaling and lipogenesis","volume":"19","author":"Key","year":"2017","journal-title":"Cell Rep"},{"key":"10.1016\/j.ebiom.2021.103287_bib0011","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.45100","article-title":"Impaired ABCA1\/ABCG1-mediated lipid efflux in the mouse retinal pigment epithelium (RPE) leads to retinal degeneration","volume":"8","author":"Storti","year":"2019","journal-title":"Elife"},{"key":"10.1016\/j.ebiom.2021.103287_bib0012","doi-asserted-by":"crossref","first-page":"343","DOI":"10.3389\/fphys.2018.00343","article-title":"Tangshen formula attenuates diabetic nephropathy by promoting ABCA1-mediated renal cholesterol efflux in db\/db mice","volume":"9","author":"Liu","year":"2018","journal-title":"Front Physiol"},{"issue":"11","key":"10.1016\/j.ebiom.2021.103287_bib0013","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1161\/CIRCRESAHA.114.303454","article-title":"Humans with atherosclerosis have impaired ABCA1 cholesterol efflux and enhanced high-density lipoprotein oxidation by myeloperoxidase","volume":"114","author":"Shao","year":"2014","journal-title":"Circ Res"},{"issue":"38","key":"10.1016\/j.ebiom.2021.103287_bib0014","doi-asserted-by":"crossref","first-page":"13125","DOI":"10.1523\/JNEUROSCI.1937-12.2012","article-title":"Abca1 deficiency affects Alzheimer's disease-like phenotype in human ApoE4 but not in ApoE3-targeted replacement mice","volume":"32","author":"Fitz","year":"2012","journal-title":"J Neurosci"},{"issue":"9","key":"10.1016\/j.ebiom.2021.103287_bib0015","doi-asserted-by":"crossref","first-page":"6298","DOI":"10.1073\/pnas.092327399","article-title":"Leukocyte ABCA1 controls susceptibility to atherosclerosis and macrophage recruitment into tissues","volume":"99","author":"van Eck","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"10.1016\/j.ebiom.2021.103287_bib0016","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1161\/CIRCRESAHA.114.300738","article-title":"ATP-binding cassette transporters, atherosclerosis, and inflammation","volume":"114","author":"Westerterp","year":"2014","journal-title":"Circ Res"},{"issue":"7","key":"10.1016\/j.ebiom.2021.103287_bib0017","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1161\/ATVBAHA.115.305547","article-title":"ABCA1 and Inflammation: from animal models to humans","volume":"35","author":"Bi","year":"2015","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"7","key":"10.1016\/j.ebiom.2021.103287_bib0018","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1161\/ATVBAHA.114.304959","article-title":"Increased systemic and plaque inflammation in ABCA1 mutation carriers with attenuation by statins","volume":"35","author":"Bochem","year":"2015","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ebiom.2021.103287_bib0019","doi-asserted-by":"crossref","first-page":"e08009","DOI":"10.7554\/eLife.08009","article-title":"LXRs link metabolism to inflammation through Abca1-dependent regulation of membrane composition and TLR signaling","volume":"4","author":"Ito","year":"2015","journal-title":"Elife"},{"issue":"4","key":"10.1016\/j.ebiom.2021.103287_bib0020","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1159\/000358675","article-title":"Insulin-sensitizing effect of LXR agonist T0901317 in high-fat fed rats is associated with restored muscle GLUT4 expression and insulin-stimulated AS160 phosphorylation","volume":"33","author":"Baranowski","year":"2014","journal-title":"Cell Physiol Biochem"},{"issue":"19","key":"10.1016\/j.ebiom.2021.103287_bib0021","doi-asserted-by":"crossref","first-page":"2978","DOI":"10.1002\/1873-3468.12702","article-title":"Liver X receptors link lipid metabolism and inflammation","volume":"591","author":"Schulman","year":"2017","journal-title":"FEBS Lett"},{"issue":"1","key":"10.1016\/j.ebiom.2021.103287_bib0022","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00395-015-0520-7","article-title":"Emerging role of liver X receptors in cardiac pathophysiology and heart failure","volume":"111","author":"Cannon","year":"2016","journal-title":"Basic Res Cardiol"},{"issue":"22","key":"10.1016\/j.ebiom.2021.103287_bib0023","doi-asserted-by":"crossref","first-page":"2831","DOI":"10.1101\/gad.850400","article-title":"Role of LXRs in control of lipogenesis","volume":"14","author":"Schultz","year":"2000","journal-title":"Genes Dev"},{"issue":"2","key":"10.1016\/j.ebiom.2021.103287_bib0024","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.cmet.2016.07.016","article-title":"Beneficial and adverse effects of an LXR agonist on human lipid and lipoprotein metabolism and circulating neutrophils","volume":"24","author":"Kirchgessner","year":"2016","journal-title":"Cell Metab"},{"issue":"1","key":"10.1016\/j.ebiom.2021.103287_bib0025","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1021\/acsptsci.0c00149","article-title":"Discovery of nonlipogenic ABCA1 inducing compounds with potential in Alzheimer's disease and Type 2 diabetes","volume":"4","author":"Ben Aissa","year":"2021","journal-title":"ACS Pharmacol Transl Sci"},{"issue":"12","key":"10.1016\/j.ebiom.2021.103287_bib0026","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1194\/jlr.D018051","article-title":"A sensitive assay for ABCA1-mediated cholesterol efflux using BODIPY-cholesterol","volume":"52","author":"Sankaranarayanan","year":"2011","journal-title":"J Lipid Res"},{"issue":"8","key":"10.1016\/j.ebiom.2021.103287_bib0027","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1194\/jlr.R034025","article-title":"New insights into the determination of HDL structure by apolipoproteins: thematic review series: high density lipoprotein structure, function, and metabolism","volume":"54","author":"Phillips","year":"2013","journal-title":"J Lipid Res"},{"issue":"29","key":"10.1016\/j.ebiom.2021.103287_bib0028","doi-asserted-by":"crossref","first-page":"30168","DOI":"10.1074\/jbc.M403765200","article-title":"Probucol inactivates ABCA1 in the plasma membrane with respect to its mediation of apolipoprotein binding and high density lipoprotein assembly and to its proteolytic degradation","volume":"279","author":"Wu","year":"2004","journal-title":"J Biol Chem"},{"issue":"3","key":"10.1016\/j.ebiom.2021.103287_bib0029","doi-asserted-by":"crossref","first-page":"E740","DOI":"10.1152\/ajpendo.00302.2006","article-title":"Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes","volume":"292","author":"Creely","year":"2007","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.ebiom.2021.103287_bib0030","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3389\/fcell.2016.00061","article-title":"In vitro modulation of the LPS-induced proinflammatory profile of hepatocytes and macrophages- approaches for intervention in obesity?","volume":"4","author":"Kheder","year":"2016","journal-title":"Front Cell Dev Biol"},{"issue":"44","key":"10.1016\/j.ebiom.2021.103287_bib0031","doi-asserted-by":"crossref","first-page":"30538","DOI":"10.1074\/jbc.M114.600833","article-title":"Amyloid-beta pathology and APOE genotype modulate retinoid X receptor agonist activity in vivo","volume":"289","author":"Tai","year":"2014","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ebiom.2021.103287_bib0032","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s12868-015-0208-9","article-title":"Re-engineering a neuroprotective, clinical drug as a procognitive agent with high in vivo potency and with GABAA potentiating activity for use in dementia","volume":"16","author":"Luo","year":"2015","journal-title":"BMC Neurosci"},{"issue":"2","key":"10.1016\/j.ebiom.2021.103287_bib0033","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1210\/me.2008-0198","article-title":"Significance and mechanism of CYP7a1 gene regulation during the acute phase of liver regeneration","volume":"23","author":"Zhang","year":"2009","journal-title":"Mol Endocrinol"},{"issue":"40","key":"10.1016\/j.ebiom.2021.103287_bib0034","doi-asserted-by":"crossref","first-page":"16184","DOI":"10.1073\/pnas.1213343109","article-title":"Insulin stimulation of SREBP-1c processing in transgenic rat hepatocytes requires p70 S6-kinase","volume":"109","author":"Owen","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"issue":"11","key":"10.1016\/j.ebiom.2021.103287_bib0035","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1016\/S0022-2275(20)31498-X","article-title":"Pivotal role of ABCA1 in reverse cholesterol transport influencing HDL levels and susceptibility to atherosclerosis","volume":"42","author":"Attie","year":"2001","journal-title":"J Lipid Res"},{"issue":"1","key":"10.1016\/j.ebiom.2021.103287_bib0036","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.bbalip.2012.07.019","article-title":"Lysoglycerophospholipids in chronic inflammatory disorders: the PLA(2)\/LPC and ATX\/LPA axes","volume":"1831","author":"Sevastou","year":"2013","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"10.1016\/j.ebiom.2021.103287_bib0037","doi-asserted-by":"crossref","first-page":"50","DOI":"10.15420\/ecr.2018.33.1","article-title":"The role of inflammation in diabetes: current concepts and future perspectives","volume":"14","author":"Tsalamandris","year":"2019","journal-title":"Eur Cardiol"},{"issue":"11","key":"10.1016\/j.ebiom.2021.103287_bib0038","doi-asserted-by":"crossref","first-page":"7604","DOI":"10.1073\/pnas.112059299","article-title":"Synthetic LXR ligand inhibits the development of atherosclerosis in mice","volume":"99","author":"Joseph","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"10.1016\/j.ebiom.2021.103287_bib0039","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/nrcardio.2017.115","article-title":"HDL and atherosclerotic cardiovascular disease: genetic insights into complex biology","volume":"15","author":"Rosenson","year":"2018","journal-title":"Nat Rev Cardiol"},{"issue":"11","key":"10.1016\/j.ebiom.2021.103287_bib0040","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1194\/jlr.M200169-JLR200","article-title":"Lipid metabolome-wide effects of the PPARgamma agonist rosiglitazone","volume":"43","author":"Watkins","year":"2002","journal-title":"J Lipid Res"},{"issue":"3","key":"10.1016\/j.ebiom.2021.103287_bib0041","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1021\/pr401230s","article-title":"Rosiglitazone and fenofibrate exacerbate liver steatosis in a mouse model of obesity and hyperlipidemia. A transcriptomic and metabolomic study","volume":"13","author":"Rull","year":"2014","journal-title":"J Proteome Res"},{"issue":"12","key":"10.1016\/j.ebiom.2021.103287_bib0042","doi-asserted-by":"crossref","first-page":"3776","DOI":"10.2337\/db16-0512","article-title":"Metformin effect on nontargeted metabolite profiles in patients with type 2 diabetes and in multiple murine tissues","volume":"65","author":"Adam","year":"2016","journal-title":"Diabetes"},{"issue":"11","key":"10.1016\/j.ebiom.2021.103287_bib0043","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0207210","article-title":"A metabolome-wide characterization of the diabetic phenotype in ZDF rats and its reversal by pioglitazone","volume":"13","author":"Jonsson","year":"2018","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ebiom.2021.103287_bib0044","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.3389\/fphar.2018.01575","article-title":"A metabolomics approach to investigate kukoamine B-A potent natural product with anti-diabetic properties","volume":"9","author":"Li","year":"2018","journal-title":"Front Pharmacol"},{"issue":"1","key":"10.1016\/j.ebiom.2021.103287_bib0045","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s12010-018-2899-8","article-title":"Metabolomics based on MS in mice with diet-induced obesity and Type 2 diabetes mellitus: the effect of vildagliptin, metformin, and their combination","volume":"188","author":"Tomasova","year":"2019","journal-title":"Appl Biochem Biotechnol"},{"issue":"2","key":"10.1016\/j.ebiom.2021.103287_bib0046","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jcjd.2019.05.008","article-title":"Metformin and dipeptidyl peptidase-4 inhibitor differentially modulate the intestinal microbiota and plasma metabolome of metabolically dysfunctional mice","volume":"44","author":"Ryan","year":"2020","journal-title":"Can J Diabetes"},{"issue":"8","key":"10.1016\/j.ebiom.2021.103287_bib0047","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1194\/jlr.M300450-JLR200","article-title":"Raising HDL cholesterol without inducing hepatic steatosis and hypertriglyceridemia by a selective LXR modulator","volume":"45","author":"Miao","year":"2004","journal-title":"J Lipid Res"},{"issue":"7","key":"10.1016\/j.ebiom.2021.103287_bib0048","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1111\/j.1476-5381.2010.01168.x","article-title":"Low dose of the liver X receptor agonist, AZ876, reduces atherosclerosis in APOE*3Leiden mice without affecting liver or plasma triglyceride levels","volume":"162","author":"van der Hoorn","year":"2011","journal-title":"Br J Pharmacol"},{"issue":"10","key":"10.1016\/j.ebiom.2021.103287_bib0049","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1210\/me.2008-0041","article-title":"Selective partial agonism of liver X receptor alpha is related to differential corepressor recruitment","volume":"22","author":"Phelan","year":"2008","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.ebiom.2021.103287_bib0050","doi-asserted-by":"crossref","DOI":"10.1021\/acs.jmedchem.8b00045","article-title":"Recent advances in the medicinal chemistry of liver X receptors","author":"El-Gendy","year":"2018","journal-title":"J Med Chem"},{"issue":"16","key":"10.1016\/j.ebiom.2021.103287_bib0051","doi-asserted-by":"crossref","first-page":"5780","DOI":"10.1128\/MCB.23.16.5780-5789.2003","article-title":"Promoter-specific roles for liver X receptor\/corepressor complexes in the regulation of ABCA1 and SREBP1 gene expression","volume":"23","author":"Wagner","year":"2003","journal-title":"Mol Cell Biol"},{"issue":"5","key":"10.1016\/j.ebiom.2021.103287_bib0052","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1194\/jlr.M081851","article-title":"Small molecule inducers of ABCA1 and apoE that act through indirect activation of the LXR pathway","volume":"59","author":"Fan","year":"2018","journal-title":"J Lipid Res"},{"key":"10.1016\/j.ebiom.2021.103287_bib0053","article-title":"Photoaffinity labeling and quantitative chemical proteomics identify LXRbeta as the functional target of enhancers of astrocytic apoE","author":"Seneviratne","year":"2020","journal-title":"Cell Chem Biol"},{"issue":"4","key":"10.1016\/j.ebiom.2021.103287_bib0054","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1124\/mol.116.105213","article-title":"Identification of a novel liver x receptor agonist that regulates the expression of key cholesterol homeostasis genes with distinct pharmacological characteristics","volume":"91","author":"Li","year":"2017","journal-title":"Mol Pharmacol"},{"issue":"20","key":"10.1016\/j.ebiom.2021.103287_bib0055","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1002\/cmdc.201600305","article-title":"Development of tetrachlorophthalimides as liver X receptor beta (LXRbeta)-selective agonists","volume":"11","author":"Nomura","year":"2016","journal-title":"ChemMedChem"},{"issue":"5","key":"10.1016\/j.ebiom.2021.103287_bib0056","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1194\/jlr.M033977","article-title":"LXR activation by GW3965 alters fat tissue distribution and adipose tissue inflammation in ob\/ob female mice","volume":"54","author":"Archer","year":"2013","journal-title":"J Lipid Res"},{"issue":"4","key":"10.1016\/j.ebiom.2021.103287_bib0057","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1074\/jbc.M209629200","article-title":"A chemical switch regulates fibrate specificity for peroxisome proliferator-activated receptor alpha (PPARalpha) versus liver X receptor","volume":"278","author":"Thomas","year":"2003","journal-title":"J Biol Chem"},{"issue":"11","key":"10.1016\/j.ebiom.2021.103287_bib0058","doi-asserted-by":"crossref","first-page":"4431","DOI":"10.1210\/jc.2008-0782","article-title":"Stearoyl-coenzyme A desaturase 1 gene expression increases after pioglitazone treatment and is associated with peroxisomal proliferator-activated receptor-gamma responsiveness","volume":"93","author":"Yao-Borengasser","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.ebiom.2021.103287_bib0059","doi-asserted-by":"crossref","first-page":"4866","DOI":"10.1074\/jbc.M709471200","article-title":"Peroxisome proliferator-activated receptor alpha deficiency abolishes the response of lipogenic gene expression to re-feeding: restoration of the normal response by activation of liver X receptor alpha","volume":"283","author":"Hebbachi","year":"2008","journal-title":"J Biol Chem"},{"issue":"7","key":"10.1016\/j.ebiom.2021.103287_bib0060","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1172\/JCI12864","article-title":"Inhibition of RXR and PPARgamma ameliorates diet-induced obesity and type 2 diabetes","volume":"108","author":"Yamauchi","year":"2001","journal-title":"J Clin Invest"},{"issue":"4","key":"10.1016\/j.ebiom.2021.103287_bib0061","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.cmet.2005.03.001","article-title":"LXRs regulate the balance between fat storage and oxidation","volume":"1","author":"Kalaany","year":"2005","journal-title":"Cell Metab"},{"issue":"12","key":"10.1016\/j.ebiom.2021.103287_bib0062","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.2337\/diabetes.50.12.2809","article-title":"PPAR-alpha-null mice are protected from high-fat diet-induced insulin resistance","volume":"50","author":"Guerre-Millo","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.ebiom.2021.103287_bib0063","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.06328","article-title":"Fatty acid remodeling by LPCAT3 enriches arachidonate in phospholipid membranes and regulates triglyceride transport","volume":"4","author":"Hashidate-Yoshida","year":"2015","journal-title":"Elife"},{"issue":"3","key":"10.1016\/j.ebiom.2021.103287_bib0064","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1074\/jbc.M116.743575","article-title":"Identification of hepatic lysophosphatidylcholine acyltransferase 3 as a novel target gene regulated by peroxisome proliferator-activated receptor delta","volume":"292","author":"Singh","year":"2017","journal-title":"J Biol Chem"},{"issue":"10","key":"10.1016\/j.ebiom.2021.103287_bib0065","doi-asserted-by":"crossref","first-page":"3640","DOI":"10.1172\/JCI93616","article-title":"ER phospholipid composition modulates lipogenesis during feeding and in obesity","volume":"127","author":"Rong","year":"2017","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.ebiom.2021.103287_bib0066","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.atherosclerosis.2010.04.025","article-title":"LXRalpha regulates human CETP expression in vitro and in transgenic mice","volume":"212","author":"Honzumi","year":"2010","journal-title":"Atherosclerosis"},{"issue":"5","key":"10.1016\/j.ebiom.2021.103287_bib0067","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.cmet.2014.10.001","article-title":"The LXR-Idol axis differentially regulates plasma LDL levels in primates and mice","volume":"20","author":"Hong","year":"2014","journal-title":"Cell Metab"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396421000803?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396421000803?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T19:05:28Z","timestamp":1762455928000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396421000803"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":67,"alternative-id":["S2352396421000803"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2021.103287","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolomic analysis of a selective ABCA1 inducer in obesogenic challenge provides a rationale for therapeutic development","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2021.103287","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"103287"}}